Back to Agenda
Live Oral Poster Presentations I
Session Chair(s)
Vedran Raguz
Scientific Programs Specialist
DIA, Switzerland
This session is an opportunity to hear Authors present their Posters Live, followed by a Q&A portion.
Learning Objective : The European Commission’s (EC) Pharmaceutical Strategy for Europe aimed to develop a future-proof pharmaceutical policy. This study aims to assess stakeholders' views on patient-centric policy initiatives and the prospects for patient-experience data (PED), expressed in the Pharmaceutical Strategy.
Speaker(s)
Towards patient-centered pharmaceutical policy-making: Stakeholders’ perspectives on the Pharmaceutical Strategy for Europe
Io Wens, MSc
KU Leuven, Belgium
PhD Researcher
Sustainable Regulatory Framework: A toolkit of regulatory processes and tools to enable patient access and foster innovation
Anna Litsiou, PhD, MBA, MSc
AstraZeneca, United Kingdom
Director - Regulatory Policy
Advancing Patient Experience Data in Healthcare Decision-Making: Multi-stakeholders’ insights on policy ways forward
Alice Vanneste, MS, MSc
KU Leuven, Belgium
PhD Student
Data science and artificial intelligence to study the drug regulatory system: current and future avenues
Marjon Pasmooij, PhD
Dutch Medicines Evaluation Board / Utrecht University, Netherlands
Head Science Department / Associate Professor of Drug Regulatory Science
Using AI to Accelerate Medicines Development: An Evolving EU Regulatory Landscape
Antoine Manson, PharmD, MPharm
Bayer AG, France
Regulatory Policy and Innovation Specialist
Lessons Learned: A Supplier’s Perspective on Strategies for Promoting Sustainability in the Regulatory Submissions Process
Katelyn Rivas, PhD
Synterex, Inc., United States
Regulatory Medical Writer
Regulatory science considerations for cell and gene therapy in chronic diseases: cardiovascular disease as a case study
Daniel Reed, PhD
AstraZeneca, United Kingdom
Senior Regulatory Intelligence Director
Access to Medicines: Models for future Regulatory Authority and HTA body work-sharing?
Carolyn Hynes, PhD
AstraZeneca, United Kingdom
Senior Director Regulatory Intelligence
Evolving Global Regulatory Landscape for Approval of Biosimilars: Current Challenges and Future Considerations
Sevengul Car, MS, MSc
KU Leuven, Belgium
PhD researcher
Have an account?